Estrogen receptor-related receptor α (ERRα) regulates osteopontin expression through a non-canonical ERRα response element in a cell context-dependent manner

Journal of Molecular Endocrinology

Volumn 40, Issue 1-2, 2008, Pages 61-73

  Zirngibl, Ralph A ^a   Chan, Janet S M ^a   Aubin, Jane E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CELL NUCLEUS RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; OSTEOPONTIN; DNA; ERRALPHA ESTROGEN RELATED RECEPTOR; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESTROGEN RECEPTOR; MUTANT PROTEIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG TARGETING; GENE CONTROL; GENE MUTATION; GENE REPRESSION; GENE SILENCING; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; MUTAGENESIS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOSARCOMA CELL; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; DNA; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOPONTIN; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, ESTROGEN; REPRESSOR PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 39549085362     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-07-0114     Document Type: Article

References (60)

1. Aubin JE 2001 Regulation of osteoblast formation and function. Reviews in Endocrine and Metabolic Disorders 2 81-94.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA & Struhl K 1987 In Current Protocols in Molecular Biology in Current Protocols, Ed VB Chanda. New York: Wiley.
3. Bidder M, Shao JS, Charlton-Kachigian N, Loewy AP, Semenkovich CF & Towler DA 2002 Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. Journal of Biological Chemistry 277 44485-44496.
4. Bonnelye E & Aubin JE 2002 Differential expression of estrogen receptor-related receptor α and estrogen receptors α and β in osteoblasts in vivo and in vitro. Journal of Bone and Mineral Research 17 1392-1400.
5. Bonnelye E & Aubin JE 2005 Estrogen receptor-related receptor α: a mediator of estrogen response in bone. Journal of Clinical Endocrinology and Metabolism 90 3115-3121.
6. Bonnelye E, Merdad L, Kung V & Aubin JE 2001 The orphan nuclear estrogen receptor-related receptor α (ERRα) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. Journal of Cell Biology 153 971-984.
7. Bonnelye E, Kung V, Laplace C, Galson DL & Aubin JE 2002 Estrogen receptor-related receptor α impinges on the estrogen axis in bone: potential function in osteoporosis. Endocrinology 143 3658-3670.
8. Bonnelye E, Zirngibl RA, Jurdic P & Aubin JE 2007 The orphan nuclear estrogen receptor-related receptor-α regulates cartilage formation in vitro: implication of Sox9. Endocrinology 148 1195-1205.
9. Bourguet W, Germain P & Gronemeyer H 2000 Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends in Pharmacological Sciences 21 381-388.
10. Castet A, Herledan A, Bonnet S, Jalaguier S, Vanacker JM & Cavailles V 2006 Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Molecular Endocrinology 20 1035-1047.
11. Craig AM & Denhardt DT 1991 The murine gene encoding secreted phosphoprotein I (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene 100 163-171.
12. Denhardt DT, Giachelli CM & Pittling SR 2001 Role of osteopontin in cellular signaling and toxicant injury. Annual Review of Pharmacology and Toxicology 41 723-749.
13. Gaillard S, Grasfeder LL, Haeffele CL, Lobeuhofer EK, Chu TM, Wolfinger R, Kazmin D, Koves TR, Muoio DM, Chang CY et al. 2006 Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Molecular Cell 24 797-803.
14. Gaillard S, Dwyer MA & McDonnell DP 2007 Definition of the molecular basis for estrogen receptor-related receptor-α-cofactor interactions. Molecular Endocrinology 21 62-76.
15. Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G & Ravazzolo R 2004 Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiological Genomics 20 87-96.
16. Giguere V 2002 To ERR in the estrogen pathway. Trends in Endocrinology and Metabolism 13 220-225.
17. Giguere V, Yang N, Segui P & Evans RM 1988 Identification of a new class of steroid hormone receptors. Nature 331 91-94.
18. Grigoriadis AE, Petkovich PM, Ber R, Aubin JE & Heersche JN 1985 Subclone heterogeneity in a clonally-derived osteoblast-like cell line. Bone 6 249-256.
19. He B, Kemppainen JA, Voegel JJ, Gronemeyer H & Wilson EM 1999 Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain. Journal of Biological Chemistry 274 37219-37225.
20. Hullinger TG, Pan Q, Viswanathan HL & Somerman MJ 2001 TGFβ and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements. Experimental Cell Research 262 69-74.
21. Hummelshoj T, Ryder LP, Madsen HO, Odum N & Svejgaard A 2006 A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Molecular Immunology 43 980-986.
22. Huppunen J, Wohlfahrt G & Aarnisalo P 2004 Requirements for transcriptional regulation by the orphan nuclear receptor ERRγ. Molecular and Cellular Endocrinology 219 151-160.
23. Huss JM, Kopp RP & Kelly DP 2002 Peroxisome proliferator-activated receptor coactivator-1 α (PGC-1 α) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and -γ. Identification of novel leucine-rich interaction motif within PGC-1α. Journal of Biological Chemistry 277 40265-40274.
24. Jakacka M, Ito M, Weiss J, Chien P-Y, Gehm BD & Jameson JL 2001 Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. Journal of Biological Chemistry 276 13615-13621.
25. Kabe Y, Yamada J, Uga H, Yamaguchi Y, Wada T & Handa H 2005 NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Molecular and Cellular Biology 25 512-522.
26. Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M & Fournier B 2004 Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα): crystal structure of ERRα ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1α. Journal of Biological Chemistry 279 49330-49337.
27. Kalnei Y, Lwin H, Saito K, Yokoyama T, Yoshiike N, Ezaki O & Tanaka H 2005 The 2.3 genotype of ESRRA23 of the ERRα gene is associated with a higher BMI than the 2.2 genotype. Obesity Research 13 1843-1844.
28. Fa-aus RJ, Ariazi EA, Farrell ML & Mertz JE 2002 Estrogen-related receptor α1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. Journal of Biological Chemistry 277 24826-24834.
29. Kuslmer PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM & Webb P 2000 Estrogen receptor pathways to AP-1. Journal of Steroid Biochemistry and Molecular Biology 74 311-317.
30. Laflamme N, Giroux S, Loredo-Osti JC, Elfassihi L, Dodin S, Blanchet C, Morgan K, Giguere V & Rousseau F 2005 A frequent regulatory variant of the estrogen-related receptor α gene associated with BMD in French-Canadian premenopausal women. Journal of Bone and Mineral Research 20 938-944.
31. Lammi J, Huppunen J & Aarnisalo P 2004 Regulation of the ostcopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Molecular Endocrinology 18 1546-1557.
32. Lee M, Na S, Jeon D, Kim H, Choi Y & Baik M 2000 Induction of osteopontin gene expression during mammary gland involution and effects of glucocorticoid on its expression in mammary epithelial cells. Bioscience, Biotechnology, and Biochemistry 64 2225-2228.
33. Lefebvre V & Smits P 2005 Transcriptional control of chondrocyte fate and differentiation. Birth Defects Research. Part C, Embryo Today: Reviews 75 200-212.
34. Li Y, Lambert MH & Xn HE 2003 Activation of nuclear receptors: a perspective from structural genomics. Structure 11 741-746.
35. Liu R-T, Suzuki S, Takeda T & DeGroot LJ 1996 An artificial thyroid hormone receptor mutant without DNA binding can have dominant negative effect. Molecular and Cellular Endocrinology 120 85-93.
36. Majeska RJ, Nair BC & Rodan GA 1985 Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/ 2.8. Endocrinology 116 170-179.
37. Nettles KW & Greene GL 2005 Ligand control of coregulator recruitment to nuclear receptors. Annual Review of Physiology 67 309-333.
38. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF & Denhardt DT 1990 Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. PNAS 87 9995-9999.
39. Nuclear Receptors Nomenclature Committee 1999 A unified nomenclature system for the nuclear receptor superfamily. Cell 97 161-163.
40. Ogawa D, Stone JF, Takata Y, Blaschke F, Chu VH, Towler DA, Law RE, Hsueh WA & Bruemmer D 2005 Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circulation Research 96 e59-e67.
41. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang C-Y, Ballas LM, Hamilton PT, McDonnell DP et al. 1999 Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ. PNAS 96 3999-4004.
42. Park YY, Ahn SW, Kim HJ, Kim JM, Lee IK, Kang H & Choi HS 2005 An autoregulatory, loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRγ. Nucleic Acids Research 33 6756-6768.
43. Privalsky ML 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annual Review of Physiology 66 315-360.
44. Sadowski I & Ptashne M 1989 A vector tor expressing GAL4(1-147) fusions tn mammalian cells. Nucleic Acids Research 17 7539.
45. Safe S, Kim K & Kivie M 2004 Nuclear receptor-mediated transactivation through interaction with Sp proteins. In Progress in Nucleic Acid Research and Molecular Biology, vol 77, pp 1-36. Academic Press.
46. Sanyal S, Kim JY, Kim HJ, Takeda J, Lee YK, Moore DD & Choi HS 2002 Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. Journal Biological Chemistry 277 1739-1748.
47. Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AA, Miner JN & Diamond MI 2005 The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. PNAS 102 9802-9807.
48. Schreiber SN, Knutti D, Brogli K, Uhlmann T & Kralli A 2003 The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα). Journal of Biological Chemistry 278 9013-9018.
49. Schug J 2003 In Using TESS to Predict Transcription Factor Binding Sites in DNA Sequence, Ed AD Baxevanis. New York: Wiley (ch 5).
50. Shen Q & Christakos S 2005 The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. Journal of Biological Chemistry 280 40589-40598.
51. Shigeta H, Zuo W, Yang N, DiAugustine R & Teng CT 1997 The mouse estrogen receptor-related orphan receptor α1: molecular cloning and estrogen responsiveness. Journal of Molecular Endocrinology 19 299-309.
52. Sladek R, Bader JA & Giguere V 1997 The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Molecular and Cellular Biology 17 5400-5409.
53. Spiegelman BM & Heinrich R 2004 Biological control through regulated transcriptional coactivators. Cell 119 157-167.
54. Vanacker JM, Delmarre C, Guo X & Laudet V 1998 Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related α. Cell Growth and Differentiation 9 1007-1014.
55. Vanacker JM, Pettersson K, Gustafsson JA & Laudet V 1999a Transcriptional targets shared by estrogen receptor - related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ. EMBO Journal 18 4270-4279.
56. Vanacker JM, Bonnelye E, Chopin-Delannoy S, Delmarre C, Cavailles V & Laudet V 1999b Transcriptional activities of the orphan nuclear receptor ERRα (estrogen receptor-related receptor-α). Molecular Endocrinology 13 764-773.
57. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach P & Franceschi R 1999 Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/ mineralization potential. Journal of Bone and Mineral Research 14 893-903.
58. Yang N, Shigeta H, Shi H & Teng CT 1996 Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. Journal of Biological Chemistry 271 5795-5804.
59. Zhang Z & Teng CT 2001 Estrogen receptor α and estrogen receptor-related receptor α1 compete for binding and coactivator. Molecular and Cellular Endocrinology 172 223-233.
60. Zhang Z, Chen K, Shih JC & Teng CT 2006 Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Molecular Endocrinology 20 1547-1561.